STOCK TITAN

Mark Van Oene sells PACB shares (NASDAQ: PACB) in February 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark Van Oene reported sales of Common stock. The filing lists two transactions: 02/17/2026 sale of 129,790 shares for $204,549.04 and 02/18/2026 sale of 55,107 shares for $89,769.30. The filing also lists Restricted Stock to be sold on 03/02/2026.

Positive

  • None.

Negative

  • None.

Insights

Reported insider sales by Mark Van Oene on consecutive dates.

The filing itemizes two open-market sales: $204,549.04 for 129,790 shares on 02/17/2026 and $89,769.30 for 55,107 shares on 02/18/2026. These amounts are stated verbatim in the excerpt.

Timing and motivation are not disclosed in the excerpt; subsequent filings may provide context. Cash‑flow recipients are the selling holder as shown; the excerpt also lists restricted stock planned for sale on 03/02/2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales did Mark Van Oene report for PACB?

Mark Van Oene reported two sales: 129,790 shares on 02/17/2026 for $204,549.04 and 55,107 shares on 02/18/2026 for $89,769.30. The filing lists these transactions verbatim.

Does the filing show any planned sales for PACB restricted stock?

Yes. The excerpt lists Restricted Stock to be sold on 03/02/2026 by the issuer. The entry appears under "Securities To Be Sold" with the listed date in the excerpt.

Who is the broker or intermediary shown in the Form 144?

The filing names Morgan Stanley Smith Barney LLC, Executive Financial Services with an address at 1 New York Plaza. That broker is listed in the filer information section of the excerpt.

Are the sale proceeds and dates provided in the PACB excerpt?

Yes. The excerpt provides transaction dates and proceeds: $204,549.04 for the 02/17/2026 sale and $89,769.30 for the 02/18/2026 sale. Figures are shown verbatim in the text.
Pacific Biosc

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Latest SEC Filings

PACB Stock Data

458.90M
275.01M
Medical Devices
Laboratory Analytical Instruments
Link
United States
MENLO PARK